• Rare Disease News
  • [email protected]
Facebook-f Instagram Linkedin-in Pinterest Twitter
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet Our Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Memes
    • Events
    • Patient Worthy FAQs
  • Listen
  • Languages
    • Spanish / Español
    • Russian / русский
    • French / Français
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet Our Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Memes
    • Events
    • Patient Worthy FAQs
  • Listen
  • Languages
    • Spanish / Español
    • Russian / русский
    • French / Français
  • Contact
  • Join PW

Daily Archives: August 12, 2021

Home » Archives for August 12, 2021
Eplontersen Trial Enrollment for hATTR Completed
rawpixel / Pixabay

Eplontersen Trial Enrollment for hATTR Completed

  • Post author:Jessica Lynn
  • Post published:August 12, 2021
  • Post category:Amyloidosis/Hereditary ATTR Amyloidosis

Currently, there are no treatments available for patients with hereditary ATTR amyloidosis (hATTR); most available therapies are designed to aid with symptom management. However, biotechnology company and RNA-targeted therapeutics leader…

Continue Reading Eplontersen Trial Enrollment for hATTR Completed
Rituximab for ANCA-Associated Vasculitis: An Overview of Clinical Trials
source: pixabay.com

Rituximab for ANCA-Associated Vasculitis: An Overview of Clinical Trials

  • Post author:James Moore
  • Post published:August 12, 2021
  • Post category:Microscopic Polyangiitis/Vasculitis

According to a story on the Renal Fellow Network, rituximab has emerged in recent years as an effective therapy for ANCA-associated vasculitis (AAV). This is a group of autoimmune diseases…

Continue Reading Rituximab for ANCA-Associated Vasculitis: An Overview of Clinical Trials
Study Shows Brentuximab Vedotin Beneficial for ALCL
source: pixabay.com

Study Shows Brentuximab Vedotin Beneficial for ALCL

  • Post author:Jessica Lynn
  • Post published:August 12, 2021
  • Post category:Anaplastic large cell lymphoma

One key facet of the healthcare system is working to improve patient outcomes and finding new, effective, and innovative lines of treatment. According to Hematology Advisor, a study showed that…

Continue Reading Study Shows Brentuximab Vedotin Beneficial for ALCL
Compassion Corner: Compassion versus Depersonalization in Healthcare

Compassion Corner: Compassion versus Depersonalization in Healthcare

  • Post author:Rose Duesterwald
  • Post published:August 12, 2021
  • Post category:Rare Disease

Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

Continue Reading Compassion Corner: Compassion versus Depersonalization in Healthcare
What To Do In Case of Vaccine Induced Immune Thrombocytopenia and Thrombosis
ulleo / Pixabay

What To Do In Case of Vaccine Induced Immune Thrombocytopenia and Thrombosis

  • Post author:Kendall Mason
  • Post published:August 12, 2021
  • Post category:COVID-19/Immune thrombocytopenia

While extremely rare, it is important to be prepared in case of vaccine-induced immune thrombocytopenia and thrombosis (VITT). This condition only occurs in 14.2 of every million COVID-19 vaccine doses,…

Continue Reading What To Do In Case of Vaccine Induced Immune Thrombocytopenia and Thrombosis
First Patient Dosed in OTX-TKI Trial for Wet AMD
source: pixabay.com

First Patient Dosed in OTX-TKI Trial for Wet AMD

  • Post author:Jessica Lynn
  • Post published:August 12, 2021
  • Post category:Wet macular degeneration

Clinical trials are important tools in determining the safety, efficacy, and tolerability of new therapeutic options. So it is important to learn when patients are dosed, what those dosages are,…

Continue Reading First Patient Dosed in OTX-TKI Trial for Wet AMD
PINK1 and Parkin Genes Associated with Parkinson’s Disease
source: pixabay.com

PINK1 and Parkin Genes Associated with Parkinson’s Disease

  • Post author:Rose Duesterwald
  • Post published:August 12, 2021
  • Post category:Parkinson's Disease

  A recent article in Genetic Engineering and Biology News describes a study conducted by Gladstone Institute researchers that brings new insights to the role of genes in connection with…

Continue Reading PINK1 and Parkin Genes Associated with Parkinson’s Disease
ICYMI: Researchers Earn $2.95M NIH Grant to Study AFib
PublicDomainPictures / Pixabay

ICYMI: Researchers Earn $2.95M NIH Grant to Study AFib

  • Post author:Jessica Lynn
  • Post published:August 12, 2021
  • Post category:Atrial Fibrillation

  Grants offer helpful funding for medical research and scientific development. In case you missed it, researchers from Cleveland Clinic and Case Western Reserve University earned a $2.95M grant from…

Continue Reading ICYMI: Researchers Earn $2.95M NIH Grant to Study AFib
LP-184 for Pancreatic Cancer Granted Orphan Drug Designation
mohamed_hassan / Pixabay

LP-184 for Pancreatic Cancer Granted Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:August 12, 2021
  • Post category:Pancreatic Cancer

On August 11, 2021, biopharmaceutical company Lantern Pharma, Inc. ("Lantern") shared the news that its small molecule drug candidate, LP-184 (hydroxyureamethylacylfulvene), received Orphan Drug designation from the FDA. This status…

Continue Reading LP-184 for Pancreatic Cancer Granted Orphan Drug Designation

OF INTEREST


XLH Image


X-Linked Hypophosphatemia: Unnderstanding this Hereditary, Progressive, and Lifelong Condition


podcast setup on a desk


Catalyst’s LEMS Aware Podcast Helps Connect Patients

Patient Stories

STUDY OF THE WEEK

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

READ MORE

RARE CLASSROOM

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most mysterious diseases and conditions. This series is an opportunity to learn the basics about some of the diseases that almost no one hears much about.

READ MORE
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Policy
Privacy Policy for CA Residents
EU Privacy Notice

© Copyright Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info